, China

China sees breakthroughs in cancer research

Cancer remains amongst China’s high-priority disease areas.

China continues to innovate on their anti-cancer drug research and treatment as they make early breakthroughs in therapies derived from advanced cancer treatments, according to an outlook by Fitch Solutions.

Some of these developments include advances in monoclonal antibodies and CAR-T therapies.

Amidst a growing number of biotech start-ups in the country, China saw a 1,287% growth in life science investment from 2013 to 2018.

The country marked its first-ever approval for a Chinese anti-cancer drug when the US Food and Drug Administration authorized BeiGene’s independently developed Brukinsa (zanubrutinib) in November 2019. The company’s anti-PD-1 antibody tislelizumab was also approved by China's National Medical Products Administration earlier this year.

Cancer remains amongst China’s five high-priority disease areas, with them having the largest number of cases globally at four million per year in 2018. The country’s cancer mortality rate is also 40% higher than that of the US.

Meanwhile, the Chinese government has made several reforms on healthcare policy to manage the rising rates of incidence, including the implementation of a zero-tariff policy on anti-cancer drugs, acceptance of overseas clinical trial data, and adoption of measures to speed up the approval of cancer medicines.
 

Since you're here...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this website and in print magazine.

We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.

Let us help you drive your business forward with a good partnership!

Get Health Care Asia Magazine in your inbox

Find out who won at this year's Healthcare Asia Awards and Healthcare Asia Pharma Awards 

The event was held via video conferencing that started last 15 April.

What investment opportunities await for India’s health-tech space?

Before the pandemic, the industry focussed on wearables, lifestyle-linked problems, and more.

Singapore’s Tan Tock Seng Hospital closes wards to visitors

Two patients and two staff were infected by COVID-19.

Hygeia Healthcare buys 100% stake in Etern Group for $268m

The acquisition indirectly holds 98% of Suzhou Yongding Hospital in Jiangsu.

How reach52 bridges the gap in healthcare with tech

The unique startup aims to connect to 250 million individuals across the globe by 2030.

He Health bags internet hospital license in China

The online platform offers services such as men’s health consultations.

Indonesia's telehealth platform Halodoc bags $80m in funding

The funds will be used to deepen its penetration in key healthcare verticals in Indonesia.

South Korea eases requirements for drug imports

Pharmaceutical companies could benefit from the government’s drive to reduce regulatory uncertainty.

Taiwan's novel pharma products hit by low reimbursement prices

The low rates are discouraging the launch of new innovative products, insiders say.

Japan's liver cancer surveillance program hailed as world's best

The country established the programme for early detection of HCC in the 1980s.